About
VitalTrace develops DelivAssure, the world’s first continuous lactate biosensor for real-time fetal monitoring during childbirth to enable evidence-based clinical decisions and improve maternal and neonatal outcomes.
Explore VitalTrace's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.